67 related articles for article (PubMed ID: 6877071)
1. [Left ventricular function parameters following administration of isosorbide-5-mononitrate].
Bergbauer M
Med Welt; 1983 Jun; 34(22):642-4. PubMed ID: 6877071
[No Abstract] [Full Text] [Related]
2. Isosorbide dinitrate-induced improvement in left ventricular ejection fraction during exercise in coronary arterial disease.
Steele PP; Rainwater J; Jensen D; Vogel RA; Battock D
Chest; 1978 Nov; 74(5):526-30. PubMed ID: 738090
[No Abstract] [Full Text] [Related]
3. [Changes of the systolic variations of the left ventricle induced by isosorbitol dinitrate in patients with chronic coronary insufficiency].
Savioli RM; Del Nero E; Ortiz J; Rangel FA; Barretto AC; Papaléo Netto M; Diament J; Tranchesi J
Arq Bras Cardiol; 1977 Dec; 30(6):441-4. PubMed ID: 614003
[No Abstract] [Full Text] [Related]
4. [Hemodynamic effects of isosorbide-5-mononitrate in ischemic cardiopathy].
Russo G; Tolaro S; Monaco O; Greco G; Grassi R; Monaco A; Calvi V; Felis S; Tamburino C; Giuffrida G
Cardiologia; 1988 Mar; 33(3):291-5. PubMed ID: 3401892
[No Abstract] [Full Text] [Related]
5. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
Smolarz A; Seeliger S; Glocke M
Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
[No Abstract] [Full Text] [Related]
6. Hemodynamic effects of isosorbide-5-mononitrate in acute and chronic treatment of coronary heart disease.
Schuster P; Trieb G; Wiechmann HW
Z Kardiol; 1983; 72 Suppl 3():251-4. PubMed ID: 6666229
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of isosorbide-5-mononitrate in the prevention of myocardial ischemia induced by ergonovine and by hand-grip tests.
Distante A; Lombardi M; Moscarelli E; Morales MA; Sabino F; L'Abbate A
Z Kardiol; 1985; 74 Suppl 4():25-31. PubMed ID: 4096068
[No Abstract] [Full Text] [Related]
8. [Effect of isosorbide-5-mononitrate (IS-5-MN) on left ventricular hemodynamics].
Mehmel HC; Ruffmann K; Schwarz F; Manthey J; Kübler W
Med Welt; 1981 Apr; 32(14A):527-9. PubMed ID: 7242314
[No Abstract] [Full Text] [Related]
9. [Steady state kinetics of isosorbide-5-mononitrate in patients with coronary disease].
Mannebach H; Ohlmeier H; von Möllendorff E; Gleichmann U; Abshagen U
Med Welt; 1981 Apr; 32(14A):517-20. PubMed ID: 7242311
[No Abstract] [Full Text] [Related]
10. [Effectiveness of the delayed-action form of isosorbide 5-mononitrate in ischemic heart disease].
Hůla J; Trhlíková M
Vnitr Lek; 1991 Mar; 37(3):248-54. PubMed ID: 2031313
[TBL] [Abstract][Full Text] [Related]
11. [Isosorbide mononitrate or dinitrate in coronary disease?].
Schanzenbächer P; Kochsiek K
Dtsch Med Wochenschr; 1983 May; 108(21):807-9. PubMed ID: 6851870
[No Abstract] [Full Text] [Related]
12. Evaluation of left ventricular function during routine cardiac catheterization: usefulness of DP-DT measurements in clinical cases.
Dubiel J; Gensini GG; Dacosta BC; Kelly AE
G Ital Cardiol; 1971; 1(4):302-11. PubMed ID: 5126212
[No Abstract] [Full Text] [Related]
13. [Hemodynamic changes at rest and during stress following isosorbide-5-mononitrate therapy in patients with coronary disease].
Isbary J; Doering W; Wauer B; Greding H; König E
Med Welt; 1981 Apr; 32(14A):530-4. PubMed ID: 7242315
[No Abstract] [Full Text] [Related]
14. Comparison of effects of isosorbide dinitrate and hydralazine on left ventricular function by M-mode echocardiography.
Baldwa VS; Sanghvi S; Gupta K; Verma AR
Indian Heart J; 1985; 37(5):303-7. PubMed ID: 3833650
[No Abstract] [Full Text] [Related]
15. [Echocardiographic evaluation of heart function before and after administration of isosorbide dinitrate in patients with acute myocardial infarct].
Marrara JP; Bellotti G; de Moraes AV; Pileggi F; Armelin E; del Castillo JM; Tranchesi J; Ramires JA; Décourt LV
Arq Bras Cardiol; 1978 Oct; 31(5):281-9. PubMed ID: 747532
[No Abstract] [Full Text] [Related]
16. [Comparison of the effectiveness of olicard 40 retard and cardonit 40 prolongatum preparations in treatment of stable coronary heart disease].
Kurpesa M; Krzemińska-Pakuła M; Kedzia E; Trzos E; Musiał W; Peruga Z
Wiad Lek; 1994 Aug; 47(15-16):587-90. PubMed ID: 7716955
[TBL] [Abstract][Full Text] [Related]
17. [Hemodynamic effect of 20 mg and 50 mg of 5-isosorbide mononitrate in acute and chronic therapy].
Jansen W; Osterspey A; Fuchs M; Tauchert M; Schell U; Weste S; Hombach V
Med Welt; 1982 Dec; 33(48):1756-62. PubMed ID: 6818416
[No Abstract] [Full Text] [Related]
18. [Long-term tolerance and therapeutic coronary effect of isosorbide-5-mononitrate. Open multicenter study of ISMO 20].
Uberbacher HJ; Glocke M; Abshagen U
MMW Munch Med Wochenschr; 1983 Jan; 125(4):76-8. PubMed ID: 6402686
[No Abstract] [Full Text] [Related]
19. [Ventricular volume, expulsion fraction and median fibrillar contraction speed in patients with coronary disease before and after administration of nitrates].
Brandt R; Goppel L; Redl A; Dacian S; Rudolph W
Z Kardiol; 1975; Suppl 2():60. PubMed ID: 1199363
[No Abstract] [Full Text] [Related]
20. [The long-acting effects of isosorbide dinitrate on left ventricular performance in congestive heart insufficiency. Phonocardiographic study].
Barretto AC; Savioli RM; Lima EV; Martinelli Filho M; Mady C; Del Nero E
Arq Bras Cardiol; 1980 Jan; 34(1):67-71. PubMed ID: 7406740
[No Abstract] [Full Text] [Related]
[Next] [New Search]
